TAIWAN · TWSE / TPEx
PET PHARM BIO
吉晟生 · 7762 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$51.901 month -3.9% · 1 year -37.4%
Directors and supervisors hold10,077,86217.3% of shares issued
Of which pledged0.0%0
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 吉晟藥品股份有限公司 | Chairman · Director | 4,200,000 | 4,320,212 | 7.44% | — | — |
| 楊朝堂 | Chairman (corporate representative) · Other | — | 0 | — | — | 169,681 |
| 林亮光 | Director (corporate representative) · President · Assistant vice president | — | 813,639 | 1.40% | — | — |
| 吉帝藥品股份有限公司 | Director | 2,690,000 | 2,766,993 | 4.76% | — | — |
| 江政起 | Director (corporate representative) | — | 462,879 | 0.80% | — | 96,772 |
| 貝克西弗股份有限公司 | Director | 2,915,335 | 2,990,657 | 5.15% | — | 40,711 |
| 陳繼光 | Director (corporate representative) | — | 150,178 | 0.26% | — | — |
| 蔡詩辰 | Independent director | — | 0 | — | — | — |
| 黃詩瑩 | Independent director | — | 0 | — | — | — |
| 錢瑩龍 | Independent director | — | 0 | — | — | — |
| 吳惠玲 | Assistant vice president | — | 41,151 | 0.07% | — | — |
| 高志浩 | Assistant vice president | — | 748,670 | 1.29% | — | 385,900 |
| 蔡智仁 | Chief financial officer · Chief accountant · Other | — | 75,271 | 0.13% | — | 82,889 |